Ana Vigil-Peleteiro
Salamanca, CL 37007, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Secreted chimeric proteins as a strategy to correct SOX17 deficiency and attenuate the malignant phenotype of cholangiocarcinoma cells: a proof-of-concept study.
Journal: Acta pharmacologica Sinica
Published: December 19, 2025
Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 04, 2024
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 09, 2023
Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma.
Journal: Cancers
Published: June 29, 2020
Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma.
Journal: Cells
Published: January 25, 2020
The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis.
Journal: Hepatology (Baltimore, Md.)
Published: May 29, 2018
Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 26, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026